PIP-AMITRIPTYLINE amitriptyline hydrochloride 25mg tablet blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

amitriptyline hydrochloride, Quantity: 25 mg

Disponível em:

Ipca Pharma (Australia) Pty Ltd

DCI (Denominação Comum Internacional):

amitriptyline hydrochloride

Forma farmacêutica:

Tablet

Composição:

Excipient Ingredients: magnesium stearate; lactose monohydrate; crospovidone; titanium dioxide; purified talc; maize starch; microcrystalline cellulose; quinoline yellow aluminium lake; hypromellose; macrogol 6000; colloidal anhydrous silica

Via de administração:

Oral

Unidades em pacote:

20, 50 and 100

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.

Resumo do produto:

Visual Identification: Yellow colour, circular, biconvex, film coated tablets with 'IA' over '25' debossed on one side and plain on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Registered

Data de autorização:

2014-08-22